Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Figlin, R' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 38 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Belldegrun, A; Tso, CL; Zisman, A; Naitoh, J; Said, J; Pantuck, AJ; Hinkel, A; de Kernion, J; Figlin, R
      Interleukin 2 gene therapy for prostate cancer: Phase I clinical trial andbasic biology

      HUMAN GENE THERAPY
    2. Tso, CL; Zisman, A; Pantuck, A; Calilliw, R; Hernandez, JM; Paik, S; Nguyen, D; Gitlitz, B; Shintaku, PI; de Kernion, S; Figlin, R; Belldegrun, A
      Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 andGranulocyte/Monocyte-Colony stimulating factor

      CANCER RESEARCH
    3. Hinkel, A; Tso, CL; Gitlitz, BJ; Neagos, N; Schmid, I; Paik, SH; deKernion, J; Figlin, R; Belldegrun, A
      Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinoma

      JOURNAL OF IMMUNOTHERAPY
    4. Small, EJ; Figlin, R; Petrylak, D; Vaughn, DJ; Sartor, O; Horak, I; Pincus, R; Kremer, A; Bowden, C
      A phase II pilot study of KW-2189 in patients with advanced renal cell carcinoma

      INVESTIGATIONAL NEW DRUGS
    5. Tsui, KH; Shvarts, O; Smith, RB; Figlin, R; DeKernion, JB; Belldegrun, A
      Renal cell carcinoma: Prognostic significance of incidentally detected tumors

      JOURNAL OF UROLOGY
    6. Tsui, KH; Shvarts, O; Barbaric, Z; Figlin, R; DeKernion, JB; Belldegrun, A
      Is adrenalectomy a necessary component of radical nephrectomy? UCLA experience with 511 radical nephrectomies

      JOURNAL OF UROLOGY
    7. Mulders, P; Tso, CL; Gitlitz, B; Kaboo, R; Hinkel, A; Frand, S; Kiertscher, S; Roth, MD; deKernion, J; Figlin, R; Belldegrun, A
      Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: Implications for live kidney cancer vaccines

      CLINICAL CANCER RESEARCH
    8. Cangiano, T; Liao, J; Naitoh, J; Dorey, F; Figlin, R; Belldegrun, A
      Sarcomatoid renal cell carcinoma: Biologic behavior, prognosis, and response to combined surgical resection and immunotherapy

      JOURNAL OF CLINICAL ONCOLOGY
    9. Figlin, R
      Serum C-reactive protein level and the impact of cytoreductive surgery in patients with metastatic renal cell carcinoma. Comment

      JOURNAL OF UROLOGY
    10. Naitoh, J; Kaplan, A; Dorey, F; Figlin, R; Belldegrun, A
      Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: Long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy

      JOURNAL OF UROLOGY
    11. MULDERS P; TSO CL; PANG S; KABOO R; MCBRIDE WH; HINKEL A; GITLITZ B; DANNULL J; FIGLIN R; BELLDEGRUN A
      ADENOVIRUS-MEDIATED INTERLEUKIN-2 PRODUCTION BY TUMORS INDUCES GROWTHOF CYTOTOXIC TUMOR-INFILTRATING LYMPHOCYTES AGAINST HUMAN RENAL-CELL CARCINOMA

      Journal of immunotherapy
    12. VOKES EE; FIGLIN R; HOCHSTER H; LOTZE M; RYBAK ME
      A PHASE-II STUDY OF RECOMBINANT HUMAN INTERLEUKIN-4 FOR ADVANCED OR RECURRENT NONSMALL CELL LUNG-CANCER

      The cancer journal from Scientific American
    13. NAITOH J; KABOO R; TSO CL; HINKEL A; STILES A; FIGLIN R; BELLDEGRUN A
      IMMUNOLOGICAL EFFECTS OF INTERLEUKIN-2 (IL-2) GENE-THERAPY IN PROSTATE-CANCER (CAP)

      The Journal of urology
    14. CANGIANO TG; LIAO JL; NAITOH J; DOREY F; FIGLIN R; BELLDEGRUN A
      SARCOMATOID VARIANT RENAL-CELL CARCINOMA - BIOLOGIC BEHAVIOR, PROGNOSIS, AND RESPONSE TO COMBINED SURGICAL RESECTION AND ADJUVANT IMMUNOTHERAPY

      The Journal of urology
    15. NAITOH J; TSO CL; KABOO R; STILES A; FIGLIN R; BELLDEGRUN A
      INTRAPROSTATIC INTERLEUKIN-2 (IL-2) GENE-THERAPY - PRELIMINARY-RESULTS OF A PHASE-I CLINICAL-TRIAL FOR THE TREATMENT OF LOCALLY ADVANCED PROSTATE-CANCER (CAP)

      The Journal of urology
    16. FIGLIN R; GITLITZ B; FRANKLIN J; DOREY F; MOLDAWER N; RAUSCH J; DEKERNION J; BELLDEGRUN A
      INTERLEUKIN-2-BASED IMMUNOTHERAPY FOR THE TREATMENT OF METASTATIC RENAL-CELL CARCINOMA - AN ANALYSIS OF 203 CONSECUTIVELY TREATED PATIENTS

      The cancer journal from Scientific American
    17. FIGLIN R; MULDERS P; GITLITZ B; BELLDEGRUN A
      CELLULAR THERAPY OF RENAL-CELL CARCINOMA PAST, PRESENT, FUTURE

      European journal of cancer
    18. STEGER GG; GNANT MF; DJAVANMARD MP; MADER RM; JAKESZ R; PIERCE W; DEKERNION JB; FIGLIN R; BELLDEGRUN A
      THE IN-VITRO EFFECTS OF INTERLEUKIN-12 UPON TUMOR-INFILTRATING LYMPHOCYTES DERIVED FROM RENAL-CELL CARCINOMA

      Journal of cancer research and clinical oncology
    19. FANUCCHI M; GLASPY J; CRAWFORD J; GARST J; FIGLIN R; SHERIDAN W; MENCHACA D; TOMITA D; OZER H; HARKER L
      EFFECTS OF POLYETHYLENE GLYCOL-CONJUGATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR ON PLATELET COUNTS AFTER CHEMOTHERAPY FOR LUNG-CANCER

      The New England journal of medicine
    20. MULDERS P; FIGLIN R; DEKERNION JB; WILTROUT R; LINEHAN M; PARKINSON D; DEWOLF W; BELLDEGRUN A
      RENAL-CELL CARCINOMA - RECENT PROGRESS AND FUTURE-DIRECTIONS

      Cancer research
    21. BELLDEGRUN A; TSO CL; KABOO R; PANG S; PIERCE W; DEKERNION JB; FIGLIN R
      NATURAL IMMUNE REACTIVITY-ASSOCIATED THERAPEUTIC RESPONSE IN PATIENTSWITH METASTATIC RENAL-CELL CARCINOMA RECEIVING TUMOR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2-BASED THERAPY

      Journal of immunotherapy with emphasis on tumor immunology
    22. GRECO FA; FIGLIN R; YORK M; EINHORN L; SCHILSKY R; MARSHALL EM; BUYS SS; FROIMTCHUK MJ; SCHULLER J; SCHUCHTER L; BUYSE M; RITTER L; MAN A; YAP AKL
      PHASE-III RANDOMIZED STUDY TO COMPARE INTERFERON ALFA-2A IN COMBINATION WITH FLUOROURACIL VERSUS FLUOROURACIL ALONE IN PATIENTS WITH ADVANCED COLORECTAL-CANCER

      Journal of clinical oncology
    23. ECONOMOU JS; BELLDEGRUN AS; GLASPY J; TOLOZA EM; FIGLIN R; HOBBS J; MELDON N; KABOO R; TSO CL; MILLER A; LAU R; MCBRIDE W; MOEN RC
      IN-VIVO TRAFFICKING OF ADOPTIVELY TRANSFERRED INTERLEUKIN-2 EXPANDED TUMOR-INFILTRATING LYMPHOCYTES AND PERIPHERAL-BLOOD LYMPHOCYTES - RESULTS OF A DOUBLE GENE MARKING TRIAL

      The Journal of clinical investigation
    24. NISHIKUBO CY; KUNKEL LA; FIGLIN R; BELLDEGRUN A; ROSEN P; ELASHOFF R; WANG HJ; TERRITO MC
      AN ASSOCIATION BETWEEN RENAL-CELL CARCINOMA AND LYMPHOID MALIGNANCIES- A CASE SERIES OF 8 PATIENTS

      Cancer
    25. WHITEHEAD RP; HAUSCHILD A; CHRISTOPHERS E; FIGLIN R
      DIABETES-MELLITUS IN CANCER-PATIENTS TREATED WITH COMBINATION INTERLEUKIN-2 AND ALPHA-INTERFERON

      Cancer biotherapy
    26. ALBERTI W; ANDERSON G; BARTOLUCCI A; BELL D; VILLALBA JB; BRODIN O; CARDIELLO C; CARTEI F; CARTEI G; CELLERINO R; CHASTANG C; CORMIER Y; COX JD; CRINO L; CROWLEY J; DAUTZENBERG B; DEPIERRE A; DIETEMANN A; DILLMAN RO; DOI O; FELD R; FIGLIN R; GANZ PA; GREEN MR; GREGOR A; HELLE PA; HERNDON JE; HITOMI S; HOST H; IMAIZUMI M; JETT JR; JOHNSON D; KAASA S; KIMURA H; KLASTERSKY J; KONDO H; KREISMAN H; KRIS MG; KUNISHIMA K; KUWAHARA O; LAD TE; LAING AH; MACBETH F; MASAOKA A; MATTSON K; MINATEL E; MIRA JG; MORI T; MOUNTAIN CF; NIEDERLE N; NIIRANEN A; NOU E; PAGE W; PATER J; PIANTADOSI S; PISTERS KMW; PYRHONEN S; QUOIX E; RAPP E; ROWELL NP; SAHMOUD T; SAWAMURA K; SCHALLIER DCC; SCOTT C; SIMPSON J; STAGG M; TERAMATSU T; TROVO MG; TSUCHIYA R; TUMMARELLO D; VANHOUTTE P; VANZANDWIJK N; VINCENT RG; WADA H; WHITE JE; WILLIAMS CJ; WOODS RL; YAMAGUCHI Y; ARRIAGADA R; CARTMELLDAVIES J; GIRLING DJ; LECHEVALIER T; MARSONI S; PARMAR MKB; PIGNON JP; REKACEWICZ C; SOUHAMI RL; STEWART LA; TARAYRE M; TINAZZI A; TONI V
      CHEMOTHERAPY IN NON-SMALL-CELL LUNG-CANCER - A METAANALYSIS USING UPDATED DATA ON INDIVIDUAL PATIENTS FROM 52 RANDOMIZED CLINICAL-TRIALS

      BMJ. British medical journal
    27. TANEJA SS; PIERCE W; FIGLIN R; BELLDEGRUN A
      IMMUNOTHERAPY FOR RENAL-CELL CARCINOMA - THE ERA OF INTERLEUKIN-2-BASED TREATMENT

      Urology
    28. BELLDEGRUN A; FRANKLIN JR; FIGLIN R
      COMMENTARY ON PROGNOSTIC FACTORS IN RENAL-CELL CARCINOMA

      The Journal of urology
    29. STEGER GG; KABOO R; DEKERNION JB; FIGLIN R; BELLDEGRUN A
      THE EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ON TUMOR-INFILTRATING LYMPHOCYTES FROM RENAL-CELL CARCINOMA

      British Journal of Cancer
    30. TANEJA SS; PIERCE W; FIGLIN R; BELLDEGRUN A
      MANAGEMENT OF DISSEMINATED KIDNEY CANCER

      Urologic clinics of North America
    31. STEGER GG; PIERCE WC; FIGLIN R; CZERNIN J; KABOO R; DEKERNION JB; OKARMA T; BELLDEGRUN A
      PATTERNS OF CYTOKINE RELEASE OF UNSELECTED AND CD8-CELL CARCINOMA TUMOR-INFILTRATING LYMPHOCYTES (TIL) - EVIDENCE FOR ENHANCED SPECIFIC KILLING OF TUMOR NECROSIS FACTOR-SECRETING IL-6 NONSECRETING TIL IN-VITROAND CORRELATION WITH COMPLETE RESPONSE IN-VIVO( SELECTED RENAL)

      Clinical immunology and immunopathology
    32. FIGLIN R; MENDOZA E; PIANTADOSI S; RUSCH V
      INTRAPLEURAL CHEMOTHERAPY WITHOUT PLEURODESIS FOR MALIGNANT PLEURAL EFFUSIONS - LCSG TRIAL-861

      Chest
    33. HATHORN RW; TSO CL; KABOO R; PANG S; FIGLIN R; SAWYERS C; DEKERNION JB; BELLDEGRUN A
      IN-VITRO MODULATION OF THE INVASIVE AND METASTATIC POTENTIALS OF HUMAN RENAL-CELL CARCINOMA BY INTERLEUKIN-2 AND OR INTERFERON-ALPHA GENE-TRANSFER/

      Cancer
    34. ABIAAD AS; STENZL A; FIGLIN R; DEKERNION JB
      LOCAL RESPONSE AND LONG-TERM RESULTS OF PREOPERATIVE M-VAC REGIMEN INREGIONALLY ADVANCED TRANSITIONAL CELL-CARCINOMA OF THE BLADDER

      European journal of cancer
    35. BELLDEGRUN A; PIERCE W; KABOO R; TSO CL; SHAU HY; TURCILLO P; MOLDAWER N; GOLUB S; DEKERNION J; FIGLIN R
      INTERFERON-ALPHA PRIMED TUMOR-INFILTRATING LYMPHOCYTES COMBINED WITH INTERLEUKIN-2 AND INTERFERON-ALPHA AS THERAPY FOR METASTATIC RENAL-CELL CARCINOMA

      The Journal of urology
    36. BELLDEGRUN A; PIERCE W; KABOO R; TSO CL; SHAU HY; TURCILLO D; MOLDAWER N; GOLLIB S; DEKERNION J; FIGLIN R
      THERAPY FOR METASTATIC RENAL-CELL CARCINOMA COMBINED WITH INTERLEUKIN-2 AND INTERFERON-ALPHA AS INTERFERON-ALPHA PRIMED TUMOR-INFILTRATING LYMPHOCYTES - REPLY

      The Journal of urology
    37. JANIK JE; SZNOL M; URBA WJ; FIGLIN R; BUKOWSKI RM; FYFE G; PIERCE WC; BELLDEGRUN A; SHARFMAN WH; SMITH JW; LONGO DL
      ERYTHROPOIETIN PRODUCTION - A POTENTIAL MARKER FOR INTERLEUKIN-2 INTERFERON-RESPONSIVE TUMORS

      Cancer
    38. CRAWFORD J; FIGLIN R; CHANG A; HAMM J; WASSERHEIT C; LEE M; CAMPION M; MANFREDA S; ISAACS R
      PHASE-I II TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-6 (RHIL-6) AND GRANULOCYTE-COLONY-STIMULATING FACTOR (RHG-CSF) FOLLOWING IFOSPHAMIDE, CARBOPLATIN AND ETOPOSIDE (ICE) CHEMOTHERAPY IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CARCINOMA (NSCLC)/

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/01/21 alle ore 05:48:39